
BD Pyxis™
1 day ago · BD Pyxis™ medication management software and medication dispensing machines enable a consistent approach to medication management across your organization to help …
Pyxis Oncology | Homepage
Nov 3, 2025 · Pyxis Oncology has assembled a differentiated portfolio of clinical assets, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies, with the …
Inline & Handheld Analytical Tools for Water Treatment | Pyxis Lab®
At Pyxis Lab® we pride ourselves on offering high quality inline sensors, handheld analytical devices, pre-mounted panel packages & fluorescent tracing chemicals that have impressed …
Pyxis Oncology (PYXS) Stock Price & Overview
6 days ago · A detailed overview of Pyxis Oncology, Inc. (PYXS) stock, including real-time price, chart, key statistics, news, and more.
PYXS Stock Price | Pyxis Oncology Inc. Stock Quote (U.S.: Nasdaq ...
3 days ago · Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for …
Pyxis Oncology, Inc. (PYXS) - Yahoo Finance
Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.
PYXS Stock Quote Price and Forecast | CNN
6 days ago · View Pyxis Oncology, Inc. PYXS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Pyxis Oncology Inc (PYXS) Stock Price & News - Google Finance
Get the latest Pyxis Oncology Inc (PYXS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Pyxis Oncology (PYXS) Stock Price, News & Analysis
3 days ago · Pyxis Oncology (NASDAQ: PYXS) is a clinical‐stage biotechnology company focused on the discovery and development of targeted oncology therapies. The company’s …
Pyxis Oncology Announces Positive Preliminary Phase 1 Data
Dec 18, 2025 · Pyxis Oncology will host a live conference call and webcast at 8:30 a.m. ET today to review the preliminary Phase 1 clinical trial data. Participants may register for the …